About Detect-ION
R&D Expertise Driving Healthcare Innovation
Detect-ION is a deep-tech startup revolutionizing detection through non-invasive diagnostics and next generation diagnostics solutions.
Founded in October 2021, we operate from a state-of-the-art 4,000-square-foot laboratory in Tampa, FL, where we tackle high-value detection challenges requiring expertise in organic chemistry, biochemistry, gas chromatography, mass spectrometry, vacuum technology, data analytics, low-power electronics, system engineering, and artificial intelligence in healthcare applications. Our innovative medical diagnostic systems integrate advanced mass spectrometry with AI medical diagnosis capabilities to drive healthcare innovation.
Our Team
Our multi-disciplinary technical team represents decades of collective experience from world-class institutions, including SRI International, Draper, NIST, University of South Florida, and beyond. This exceptional group of scientists, engineers, and innovators brings together expertise spanning analytical chemistry, biomedical engineering, artificial intelligence, and advanced instrumentation development. The Detect-ION team has played a critical role in high-profile U.S. government programs to enhance chemical detection and security intelligence, while also pioneering breakthrough advances in point-of-care molecular diagnosis and testing technologies.
What sets our team apart is not just individual expertise, but our collaborative approach to solving complex detection challenges. The team's proven track record in both fundamental research and practical implementation positions Detect-ION at the forefront of next-generation diagnostic solutions.
Technical Team
Timeline
From Detect-ION's founding in 2021 to accessible point-of-care diagnostics and global health partnerships.
Molecular Diagnostics
Has Arrived
Detect-ION stands at the forefront of healthcare innovation and next-generation sensor technologies, working alongside government agencies, research institutions, and industry leaders. The company's commitment to molecular point of care diagnostics ensures that advanced detection technologies are no longer limited to the lab—they're available when and where they're needed most.